← Leaderboards
Carol A Huff
Johns Hopkins University
$3,002,901
Attributed
$4,163,365
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $580.2K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$4,163,365 · 5
By mechanism
R01$2,901,160 · 1
K23$684,450 · 1
P01$571,859 · 1
M01$5,896 · 2
Top collaborators
- William H Matsui4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Mary Y. Armanios$14,372,703
- Carol Grieder$0
- William H Matsui$9,192,306
- Martin G Pomper$38,517,075
- Richard F. Ambinder$9,273,650
Others in their field
Top investigators on “Multiple Myeloma”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,380,351
- Larry Arthur$41,717,333
- Charles A Coltman · Southwest Oncology Group$36,988,659
- Kenneth C Anderson · Dana-Farber Cancer Inst$25,497,347
- Irene M. Ghobrial · Dana-Farber Cancer Inst$22,402,686
- Nilsa Del Carmen Ramirez · Ohio State University$22,287,552
Research focus
Multiple MyelomaClinical TrialsReportingRituximabLaboratory FindingCyclophosphamideLaboratoriesRelapseTranslatingDosePlasma CellsCellsFlow CytometryCell TypeGenerationsDrug ResistanceIbritumomab TiuxetanImmunodeficient MouseClinically RelevantCancer Stem CellBaseClinical ResearchClinical EfficacyAftercare
Grant awards (13)
Role of multiple myeloma cancer stem cells in clinical disease$580,232
R01 · FY2018 · CA · contact PI
Role of multiple myeloma cancer stem cells in clinical disease$580,232
R01 · FY2017 · CA
Role of multiple myeloma cancer stem cells in clinical disease$580,232
R01 · FY2016 · CA
Role of multiple myeloma cancer stem cells in clinical disease$580,232
R01 · FY2015 · CA
Role of multiple myeloma cancer stem cells in clinical disease$580,232
R01 · FY2014 · CA
Biostatistics and Data Management$571,859
P01 · FY2011 · CA · contact PI
HIGH DOSE CYCLOPHOSPHAMIDE AND RITUXIMAB IN MULTIPLE MYELOMA$1,238
M01 · FY2007 · RR · contact PI
Translational Research in Multiple Myeloma$136,890
K23 · FY2006 · CA · contact PI
HIGH DOSE CYCLOPHOSPHAMIDE AND RITUXIMAB IN MULTIPLE MYELOMA$4,658
M01 · FY2006 · RR · contact PI
Translational Research in Multiple Myeloma$136,890
K23 · FY2005 · CA
Translational Research in Multiple Myeloma$136,890
K23 · FY2004 · CA
Translational Research in Multiple Myeloma$136,890
K23 · FY2003 · CA
Translational Research in Multiple Myeloma$136,890
K23 · FY2002 · CA